Insulin DEGLUDEC 100units/mL and 200 units/mL solution for subcutaneous injection (Tresiba®▼) - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

Insulin DEGLUDEC 100units/mL and 200 units/mL solution for subcutaneous injection (Tresiba®▼)

Last Updated: 28 February 2018

Body System: Endocrine System

Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of insulin degludec 100units/mL and 200units/mL solution for injection (Tresiba®▼) following specialist initiation for type 1 diabetes and type 2 diabetes for specific patient groups taking into account NICE guidance and key safety implications.